Nvidia's AI Investments Send These Tech Stocks Soaring
Friday, Feb 14, 2025 3:34 pm ET
Nvidia's(NVDA -1.97%) recent disclosure of its stakes in several AI-focused companies has sent the stocks of these firms soaring. The chipmaker's investments in Arm Holdings(ARM -1.97%), SoundHound AI(SOUN -1.07%), Nano-X Imaging(NNOX -1.17%), Recursion Pharmaceuticals(RXRX -1.45%), and TuSimple Holdings(TSPH -1.57%) have all seen significant gains. Let's take a closer look at these investments and their potential impact on Nvidia's overall portfolio.

Nvidia's investment in Arm Holdings, a leading IP semiconductor company, aligns with its goal of fostering AI innovation. Arm's energy-efficient designs are crucial for AI applications, and Nvidia's GPUs are often used in conjunction with Arm-based processors. The synergy between these two companies creates a powerful combination for AI developers. Nvidia's investment in Arm, worth over $292 million as of the closing bell on July 26, has seen the stock rise nearly 68% in 2024.
Nvidia's investment in Recursion Pharmaceuticals, a clinical-stage biotechnology company, supports the development of AI-driven drug discovery. Recursion's use of AI in drug discovery aligns with Nvidia's goal of driving AI innovation in various industries. Nvidia's stake in Recursion, worth over $64.3 million as of July 26, has seen the stock rise 15% late on Wednesday night.
Nvidia's investment in SoundHound AI, a company that makes AI software for vocal recognition, aligns with its goal of expanding its ecosystem into new areas. SoundHound's voice AI technology has the potential to disrupt the market, but it faces stiff competition from established players like Amazon and Google. Nvidia's stake in SoundHound, worth over $6.6 million as of July 26, has seen the stock spike 49% late on Wednesday night.
Nvidia's investment in Nano-X Imaging, a company that uses AI in medical imaging, aligns with its goal of driving AI innovation in healthcare. Nano-X's innovative digital X-ray machine and AI-driven diagnostic tools could lead to improved patient outcomes and reduced healthcare costs. Nvidia's stake in Nano-X, worth over $770,000 as of July 26, has seen the stock skyrocket 84% late on Wednesday night.
Nvidia's investment in TuSimple Holdings, a company that focuses on autonomous driving, aligns with its goal of driving AI innovation in transportation. TuSimple's autonomous semi-trucks have the potential to revolutionize the logistics industry, but the company faces significant regulatory and technological challenges. Nvidia's stake in TuSimple, worth over $13 million as of July 26, has seen the stock leap 25% late on Wednesday night.
Nvidia's investments in these AI-focused companies provide exposure to various growing sectors, including semiconductors, medical imaging, biotechnology, voice recognition and AI, and autonomous driving. While some of these companies have shown promising growth, others are still in the early stages of development and may face financial challenges. Nvidia's focus on earnings as the primary driver of stock performance suggests that it is likely to monitor the financial performance of these companies closely and make strategic decisions based on their earnings prospects.
In conclusion, Nvidia's investments in AI-focused companies have sent the stocks of these firms soaring. These investments align with Nvidia's long-term strategic goals and create potential synergies between these companies and Nvidia's core business. While geopolitical risks associated with some of these companies may pose challenges, Nvidia's investment strategy is not primarily driven by political outcomes. Instead, the company focuses on the technological potential and strategic value of these companies. As Nvidia continues to invest in AI and related technologies, it solidifies its position as a leader in the AI-driven future.